Showing results (1891-1900 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|November 5, 2010
Phase II study of cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortiumAjjai Alva, Susan Slovin, Stephanie Daignault, et al.
Investigational New Drugs|December 21, 2010
A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancerDaniel J Renouf, Malcolm J Moore, David Hedley, et al.
Investigational New Drugs|December 3, 2010
Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAILArianna Gonelli, Oriano Radillo, Sara Drioli, et al.
Investigational New Drugs|January 6, 2011
Caspase-independent apoptosis induction of quorum-sensing autoinducer analogs against chronic myeloid leukemia K562Masaharu Hazawa, Michiko Kudo, Toshihiro Iwata, et al.
Investigational New Drugs|January 14, 2011
Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institutionAnnie Brion, Faezeh Legrand, Fabrice Larosa, et al.
Investigational New Drugs|January 12, 2011
Antimetastatic activity and low systemic toxicity of tetradecyl gallate in a preclinical melanoma mouse modelClaudriana Locatelli, Deborah Regina Carvalho, Alessandra Mascarello, et al.
Investigational New Drugs|January 12, 2011
Irinotecan and DNA-PKcs inhibitors synergize in killing of colon cancer cellsDavid Davidson, Yannick Coulombe, Veronica L Martinez-Marignac, et al.
Investigational New Drugs|October 8, 2010
Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumorsLaura Vidal, Margarita Magem, Clare Barlow, et al.
Investigational New Drugs|September 8, 2010
Cytotoxic activity of the titanium alkoxide (OPy)(2)Ti(4AP)(2) against cancer colony forming cellsElizabeth A Williamson, Timothy J Boyle, Rebecca Raymond, et al.
Investigational New Drugs|October 9, 2010
Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case reportAdeline Guais, GianFranco Baronzio, Edward Sanders, et al.
Pageof 372